Akoya surges as unsolicited buyout offer risks Quanterix merger
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 21 2025
0mins
Source: SeekingAlpha
Akoya Biosciences Acquisition Proposal: Akoya Biosciences shares surged approximately 25% after receiving an unsolicited acquisition offer of $1.40 per share in cash, which may surpass its existing merger agreement with Quanterix Corporation.
Merger Deal Context: The current merger deal with Quanterix involves a cash payment of $0.38 per share and additional shares of Quanterix, but Akoya's board continues to recommend the merger despite the new proposal.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
